Skylight Health Announces Fourth Quarter and Full Year Fiscal 2020 Earnings Conference Call

NEXT STORY
ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting
PREV STORY
Outlook on the Research Antibodies Global Market to 2025 – Development of Novel Research Antibodies Presents Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Basilea reports positive interim results from phase 2 study FIDES-01 for derazantinib in FGFR2 gene mutation- or amplification-positive patients with bile duct cancer (iCCA)

author_avatar
NASDAQ Market News

Biocartis’ Idylla(TM) Instrument and Idylla(TM) Console exempt from US FDA 510(k) notification requirements

Biocartis Group NV ('Biocartis' or the 'Company'), an innovative molecular diagnostics company (Euronext Brussels: ...

author_avatar
NASDAQ Market News

Medical/Hospital Beds Market Worth $5.23 billion by 2027- Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

author_avatar
NASDAQ Market News